Press release
Bronchodilators Market Projected to Reach USD 32.94 Billion by 2034, Growing at a CAGR of 3.4%
Bronchodilators Market
Market Description
A bronchodilator is a kind of medicine that alleviates the indication of asthma, chronic obstructive pulmonary disease (COPD), and other lung illnesses. It swiftly eases the muscle bands that consolidate around the airways. When those muscles are at ease more air is inhaled and exhaled from the lungs so one can breathe easily. They also assist in clearing mucus from the lungs.
Short-acting bronchodilators are known as prompt, comforter, or rescue medicines. These bronchodilators alleviate severe asthma indications or attacks very swiftly by unfurling the airways. The effect of inhaled bronchodilators commences within minutes subsequent to inhaling them and persists for two to four hours. Long-acting bronchodilators are utilized to offer regulation from asthma.
Get Exclusive Sample Pages of This Report:
https://www.polarismarketresearch.com/industry-analysis/bronchodilators-market/request-for-sample
Key Competitors
The competitive landscape of the market is portrayed by the existence of several pharmaceutical firms striving to advance and market productive medicines for respiratory illnesses. The list of key companies profiled are:
• AstraZeneca plc
• Boehringer Ingelheim International GmbH
• Chiesi Farmaceutici S.p.A.
• Cipla Limited
• GlaxoSmithKline plc
• Glenmark Pharmaceuticals Ltd.
• Merck & Co., Inc.
• Mylan N.V. (now part of Viatris Inc.)
• Novartis AG
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.
Bronchodilators Market Report Highlights
• Based on drug class, the beta-adrenergics segment dominates the market. These drugs, such as albuterol and levalbuterol, work by activating beta-2 adrenergic receptors, which relaxes bronchial smooth muscles and dilates airways.
• By mode of action, the long-acting segment is the fastest-growing market category. Medications such as salmeterol and formoterol provide sustained bronchodilation, making them ideal for the maintenance treatment of chronic respiratory diseases.
• North America dominates the market, driven by advanced healthcare infrastructure, high COPD prevalence, and strong regulatory support for respiratory treatments.
• Asia Pacific is the fastest-growing region due to increasing air pollution, rising healthcare investments, and a growing patient population.
Request for a Discount on this Report Before Purchase:
https://www.polarismarketresearch.com/industry-analysis/bronchodilators-market/request-for-discount-pricing
Market Drivers
Growing Cases of Respiratory Illnesses: The growing cases of respiratory conditions, especially asthma and chronic obstructive pulmonary disease (COPD), notably push the market growth. For instance, as per the report by Our World in Data, the approximated mortality per 100,000 persons in the US, India, the UK, and China from detrimental illnesses in 2021 is 37.0, 133.3, 33.8, and 75.8, respectively, placing the bronchodilators market on a growth trajectory.
Technological Progressions: Inventions in drug conveyance apparatus have improved the productivity and patient conformity of bronchodilator treatments. The advancement of progressive inhalation gadgets, such as metered-dose inhalers and dry powder inhalers, sanction accurate medication conveyance to the lungs, enhancing therapeutic results. For instance, in August 2022, Aptar Pharma obtained a worldwide patent for Pharmaxi's Orbital inhaler, a clinical-stage gadget sanctioning excessive payload dry powder conveyance to the lungs.
Segmental Division
Global Bronchodilators Market, by Disease
5.1. Key Findings
5.2. Introduction
5.2.1. Global Bronchodilators Market, by Disease, 2020-2034 (USD Billion)
5.3. Asthma
5.3.1. Global Bronchodilators Market, by Asthma, by Region, 2020-2034 (USD Billion)
5.4. COPD
5.4.1. Global Bronchodilators Market, by COPD, by Region, 2020-2034 (USD Billion)
5.5. Others
5.5.1. Global Bronchodilators Market, by Others, by Region, 2020-2034 (USD Billion)
Global Bronchodilators Market, by Route of Administration
6.1. Key Findings
6.2. Introduction
6.2.1. Global Bronchodilators Market, by Route of Administration, 2020-2034 (USD Billion)
6.3. Inhalable
6.3.1. Global Bronchodilators Market, by Inhalable, by Region, 2020-2034 (USD Billion)
6.4. Oral
6.4.1. Global Bronchodilators Market, by Oral, by Region, 2020-2034 (USD Billion)
6.5. Injection
6.5.1. Global Bronchodilators Market, by Injection, by Region, 2020-2034 (USD Billion)
Global Bronchodilators Market, by Drug Class
7.1. Key Findings
7.2. Introduction
7.2.1. Global Bronchodilators Market, by Drug Class, 2020-2034 (USD Billion)
7.3. Beta-Adrenergics
7.3.1. Global Bronchodilators Market, by Beta-Adrenergics, by Region, 2020-2034 (USD Billion)
7.4. Anticholinergics
7.4.1. Global Bronchodilators Market, by Anticholinergics, by Region, 2020-2034 (USD Billion)
7.5. Xanthine Derivatives
7.5.1. Global Bronchodilators Market, by Xanthine Derivatives, by Region, 2020-2034 (USD Billion)
7.6. Phosphodiesterase Inhibitors
7.6.1. Global Bronchodilators Market, by Phosphodiesterase Inhibitors, by Region, 2020-2034 (USD Billion)
7.7. Combination Drugs
7.7.1. Global Bronchodilators Market, by Combination Drugs, by Region, 2020-2034 (USD Billion)
Global Bronchodilators Market, by Mode of Action
8.1. Key Findings
8.2. Introduction
8.2.1. Global Bronchodilators Market, by Mode of Action, 2020-2034 (USD Billion)
8.3. Short Acting
8.3.1. Global Bronchodilators Market, by Short Acting, by Region, 2020-2034 (USD Billion)
8.4. Long Acting
8.4.1. Global Bronchodilators Market, by Long Acting, by Region, 2020-2034 (USD Billion)
Explore The Complete Comprehensive Report Here:
https://www.polarismarketresearch.com/industry-analysis/bronchodilators-market
Regional Analysis
The bronchodilators market in North America is driven by the growing existence of asthma and COPD, entrenched healthcare frameworks, and robust regulatory reinforcement for progressive respiratory therapies.
Asia Pacific is expected to witness the fastest growth attributed to growing pollution levels, growing cases of respiratory illnesses and enhancing reach to healthcare in surfacing nations such as China and India.
• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
More Trending Latest Reports by Polaris Market Research:
Dental Implants Market
https://www.polarismarketresearch.com/industry-analysis/global-dental-implants-market
Drug Discovery Services Market
https://www.polarismarketresearch.com/industry-analysis/drug-discovery-services-market
eClinical Solutions Market
https://www.polarismarketresearch.com/industry-analysis/eclinical-solutions-market
Animal Genetics Market
https://www.polarismarketresearch.com/industry-analysis/animal-genetics-market
Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter
About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bronchodilators Market Projected to Reach USD 32.94 Billion by 2034, Growing at a CAGR of 3.4% here
News-ID: 4007388 • Views: …
More Releases from Polaris Market Research & Consulting
Endoscopic Hemostasis Devices Market Soars to US$ 2,954.80 Million With Experien …
The endoscopic hemostasis devices market report offers an in-depth analysis of the rapidly growing market. It covers all the key market aspects, including market share, size, trends, and recent developments. In addition, the report assesses top regions, key segments, and the competitive landscape of the market.
The global endoscopic hemostasis devices market was valued at USD 2,066.92 million in 2024. With a compound annual growth rate (CAGR) of 3.6% from…
Wind Turbine Composites Market to Surge to US$ 31.88 Billion at a CAGR of 8.54% …
Polaris Market Research announces the release of its latest research report titled, "Wind Turbine Composites Market Size, Share, & Industry Analysis Report: By Fiber Type (Glass Fiber, Carbon Fiber, and Others), By Application, By Manufacturing Process, and By Region - Market Forecast, 2025-2034."
The report examines the market for wind turbine composites to exhibit a CAGR of 8.54% during 2025-2034. The market was valued at USD 14.07 billion in 2024 and…
Gas Separation Membrane Market Size Projected to Reach USD 1,911.34 Million by 2 …
Gas Separation Membrane Market:
The latest research report on the gas separation membrane market by Polaris Market Research offers an in-depth comprehension of a rapidly evolving sector. It covers all the key market aspects, including market share, size, trends, and recent developments. In addition, an in-depth analysis of the key regions, major segments, and competitive landscape has been provided.
The market for gas separation membrane was valued at USD 998.24 million in…
Global E-fuel Market Predicted to Reach USD 900.80 Billion by 2034, Growing at 1 …
E-fuel Market
Polaris Market Research announces the release of its latest research report titled, "E-fuel Market Size, Share, & Industry Analysis Report: By State (Liquid and Gas), By Fuel Type, By Production, By End User, and By Region - Market Forecast, 2025-2034."
The report analyzes the market for e-fuel to exhibit a compound annual growth rate (CAGR) of 18.9% during 2025-2034. The market was valued at USD 159.85 billion in 2024 and…
More Releases for Bronchodilators
Bronchodilators Market : Industry Size, Share, Growth, Forecasts 2017 - 2025
MarketResearchReports.Biz announces addition of new report "Bronchodilators Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025" to its database.
The objectives of this study are as follows:
To define, describe, and forecast the "Bronchodilators" market by type, application, component, delivery model, end user, and region
To provide detailed information regarding major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)
To analyze micromarkets with respect to individual growth…
Bronchodilators Market to Observe Strong Development by 2025
According to the report, the global Bronchodilators Market is majorly driven by an increasing focus on the development of monoclonal antibody therapy. Monoclonal antibody therapy is increasingly being used for the treatment of diseases such as tumour, which in turn has inspired market players to double their efforts and focus on the development of monoclonal antibody therapy. The positive results shown by monoclonal antibody therapy is expected to increase its…
Bronchodilators Market Size, Status and Forecast to 2025
According to the report, the global bronchodilators market is majorly driven by an increasing focus on the development of monoclonal antibody therapy. Monoclonal antibody therapy is increasingly being used for the treatment of diseases such as tumour, which in turn has inspired market players to double their efforts and focus on the development of monoclonal antibody therapy. The positive results shown by monoclonal antibody therapy is expected to increase its…
Bronchodilators Market Competitive Landscape by 2024
Bronchodilators is the medication that is taken to improve breathing and are used for treating breathing related symptoms that are associated with allergic reaction. It is also used for expanding the airways and improving the breathing capacity function of patients with chronic obstructive pulmonary disease (COPD), bronchial asthma, emphysema, and other lung diseases. Bronchodilators function by relaxing the muscle surrounding the airways. These products are available over the counter or…
Discover the Growth of the Bronchodilators Market
Bronchodilators is the medication that is taken to improve breathing and are used for treating breathing related symptoms that are associated with allergic reaction. It is also used for expanding the airways and improving the breathing capacity function of patients with chronic obstructive pulmonary disease (COPD), bronchial asthma, emphysema, and other lung diseases. Bronchodilators function by relaxing the muscle surrounding the airways. These products are available over the counter or…
Bronchodilators Market Plying for Significant Growth During 2016 - 2024
Bronchodilators is the medication that is taken to improve breathing and are used for treating breathing related symptoms that are associated with allergic reaction. It is also used for expanding the airways and improving the breathing capacity function of patients with chronic obstructive pulmonary disease (COPD), bronchial asthma, emphysema, and other lung diseases. Bronchodilators function by relaxing the muscle surrounding the airways. These products are available over the counter or…
